Glenmede Trust’s Adient ADNT Stock Holding History

Glenmede Trust’s Portfolio ADNT Stock Details ADNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$252K	Buy	13,697 +142	+1%	+$3.04K	﹤0.01%	1245
2026 Q1	$274K	Buy	+13,555	New	+$301K	﹤0.01%	1195
2020 Q4	–	Sell	-402	Closed	-$6K	–	1205
2020 Q3	$6K	Sell	402 -100	-20%	-$1.74K	﹤0.01%	2023
2020 Q2	$6K	Sell	502 -254	-34%	-$3.86K	﹤0.01%	2009
2020 Q1	$15K	Hold	756	–	–	﹤0.01%	2218
2019 Q4	$15K	Sell	756 -804	-52%	-$17.8K	﹤0.01%	2218
2019 Q3	$34K	Buy	1,560 +485	+45%	+$11.1K	﹤0.01%	1825
2019 Q2	$25K	Sell	1,075 -125	-10%	-$2.57K	﹤0.01%	1969
2019 Q1	$14K	Sell	1,200 -292	-20%	-$5.11K	﹤0.01%	2231
2018 Q4	$21K	Buy	+1,492	New	+$38.6K	﹤0.01%	1962
2018 Q3	–	Sell	-2,477	Closed	-$121K	–	1428
2018 Q2	$121K	Sell	2,477 -131	-5%	-$7.43K	﹤0.01%	1209
2018 Q1	$204K	Hold	2,608	–	–	﹤0.01%	1177
2017 Q4	$204K	Sell	2,608 -2	-0.1%	-$161	﹤0.01%	1177
2017 Q3	$218K	Buy	+2,610	New	+$185K	﹤0.01%	1197
2017 Q1	–	Sell	-7,344	Closed	-$430K	–	2658
2016 Q4	$430K	Buy	+7,344	New	+$388K	﹤0.01%	980

Other funds holding ADNT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

HHAM

HITE Hedge Asset Management Braintree, Massachusetts $1.83B AUM 34.36% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Glenmede Trust's ADNT Position: Q2 2026 in Review

Glenmede Trust increased its Adient (ADNT) stake by 1% in Q2 2026, buying an estimated $3.04K and bringing the position to 13,697 shares worth $252K. The position accounts for ﹤0.01% of the portfolio, ranked #1245.

Glenmede Trust first reported a position in ADNT in Q4 2016 and has held it in 15 quarters since. The position peaked at $430K in Q4 2016. 313 funds tracked by Wall St. Rank hold ADNT as of Q2 2026.

Glenmede Trust held 13,697 shares of Adient worth $252K as of Q2 2026.
Glenmede Trust bought 142 Adient shares in Q2 2026, an estimated $3.04K.
Adient made up ﹤0.01% of Glenmede Trust's portfolio in Q2 2026, its #1245 holding.
Glenmede Trust first reported a position in Adient in Q4 2016 and has held it in 15 quarters since.
Glenmede Trust's Adient position peaked at $430K in Q4 2016.
313 funds tracked by Wall St. Rank held Adient as of Q2 2026.

Based on Glenmede Trust's 13F filing for Q2 2026, filed 10 Aug 2026.